Pay in 4 interest-free payments of $5.48 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
As a research compound, AOD9604 UK carries a well-characterised pre-clinical and early-phase clinical research profile developed primarily through the work of Metabolic Pharmaceuticals, with published studies spanning lipid metabolism, adipose biology, 3-adrenergic receptor regulation, cartilage biology, and safety pharmacology
Furthermore, research has examined its potential for treating obesity-related metabolic illnesses, suggesting that it may offer a non-invasive method of managing these conditions
And now its emerging as a powerful tool in longevity science and functional medicine, thanks to its ability to indirectly boost NAD+ levels by slowing the rate of depletion
Human dosing, long-term safety, and drug interactions are not established
